Skip to main content
Caplight Logo









Echo Neurotechnologies

Echo Neurotechnologies

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.echo.bio/

Last Round

Series A

Jan 31, 2025

Total Funding Raised

$50M

Company Overview

Echo Neurotechnologies is a therapeutic devices company that develops neuroscience products using brain-computer interfaces to restore conversational communications for patients with severe disabilities.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIneuroprostheticsneural decodingmedical deviceneurotechnologybrain-to-speechneural signal processingassistive technologyneuromorphic hardwareimplantable electrodesmachine learningneural interfacebioelectronicsdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Echo Neurotechnologies Comparables

Compare Echo Neurotechnologies with similar companies based on industry and business-model similarity.

Echo Neurotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axoft
85%
Precision Neuroscience
84%
Synchron
83%

Echo Neurotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 31, 2025

Echo Neurotechnologies Investors

Notable investors and investment history

Echo Neurotechnologies investors
InvestorRounds
Andreessen HorowitzSeries A
PL CapitalSeries A

Echo Neurotechnologies Filings

Explore SEC and related filing metadata, where available.

Echo Neurotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Echo Neurotechnologies's valuation, stock price, and market status.

Is Echo Neurotechnologies a public or private company?

Echo Neurotechnologies is a private company.

What is the current stock price of Echo Neurotechnologies?

Echo Neurotechnologies is a private company, so its shares have no public market price. Caplight tracks Echo Neurotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Echo Neurotechnologies worth (valuation)?

Valuation information for Echo Neurotechnologies is not publicly available.

Can I buy Echo Neurotechnologies stock?

Echo Neurotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Echo Neurotechnologies's last funding round?

Echo Neurotechnologies's most recent funding round was Series A on January 31, 2025.

Who are the main investors in Echo Neurotechnologies?

Key investors in Echo Neurotechnologies include Andreessen Horowitz.

Will Echo Neurotechnologies IPO soon?

No public IPO plans have been announced for Echo Neurotechnologies.

How can I track Echo Neurotechnologies secondary market activity?

Caplight tracks bids, offers, and trades in Echo Neurotechnologies's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2023
Last FundingJan 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?